- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
- Report CAPSER, DEGODAS – JOINT DEPARTMENT OF ORTHOPEDIC TRAUMA HOSPITAL (16/10/2023 )
Report TAMDEFLO MEDIC BINH DUONG
September 26, 2023, at the hall of Binh Duong Medic Hospital.
Medbolide Joint Stock Company had a report introducing the product TAMDEFLO (deflazacort 6mg). The report took place with the participation of more than 40 Doctors and medical staff.
Company representatives presented recommendations and clinical studies demonstrating the effectiveness of the active ingredient deflazacort in treating medical conditions that respond to corticosteroids and minimizing side effects of corticosteroids.
After the report, the doctors had many discussions about the use and safety of the drug.
At the end of the report, Medbolide Company sends its thanks and hopes to continue accompanying the Hospital in bringing solutions to improve the quality of life for patients.
Readers comments